-
1h 3m 10sPart 2 | Session 8 Plenary session 11 – Managing frail and elderly patients
-
1h 1m 47sPart 2 | Session 9 Plenary session 12 – Managing end-stage disease: focus on QoL
-
58m 8sPart 1 | Session 1 Plenary session 1 – HFpEF
-
56m 38sPart 1 | Session 3 Plenary session 2 – SGLT2 updates
-
58m 54sPart 1 | Session 5 Plenary session 3 – Weight management in CRM disease
-
1h 6m 3sPart 1 | Session 7 Plenary session 4 – Guidelines implementation for acutely ill patients
-
58m 41sPart 1 | Session 8 Plenary session 5 – Mineralocorticoids antagonists in CRM disease
-
25m 15s
-
59m 5sPart 1 | Session 10 Plenary session 6 – Diuretics: old drugs, new data, new approaches
-
1h 20s
-
59m 17sPart 2 | Session 5 Plenary session 9 – Managing “metals”
e-SPACE Cardio-Renal-Metabolic 2023 was the third edition of the annual global online conference that explores how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.
Course leadership Prof Stefan Anker (Berlin, DE), Dr Javed Butler (Texas, US), Prof Antonio Ceriello (Milan, IT), Prof Tara I Chang (California, US), Prof Ian de Boer (Washington, US), Prof Peter Rossing (Copenhagen, DK) and Prof Shelley Zieroth (Winnipeg, CA) lead an interactive programme of plenary sessions, meet the expert, case discussions and satellite symposium sessions focusing on the patient journey.
For the first time, e-SPACE Cardio-Renal-Metabolic 2023 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
- Describe the complexity and interlink between the three conditions
- Discuss existing guidelines and best approaches for screening patients
- Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
- Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
Target Audience
- Cardiologists
- Nephrologists
- Diabetologists
- General Practitioners (GPs)
- HF Specialists
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Peter Rossing
Clinical Professor
Prof Peter Rossing is a Clinical Professor at University of Copenhagen, Copenhagen, DK.
His interests include complications in diabetes with focus on renal and cardiovascular complications.
He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis.
Prof Rossing is past president of the Danish Endocrine Society, and of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry.
Sankar Navaneethan
Professor of Medicine
Dr Sankar D Navaneethan is a Professor of Medicine at Baylor College of Medicine, Texas, US.
His major research interests include obesity and intentional weight loss in chronic kidney disease (CKD), cardiovascular disease in CKD, health services research and systematic reviews in nephrology.
Dr Navaneethan has been a member of the American Heart Association (AHA) Heart Disease and Stroke Statistics Committee since 2019.
Maria Luiza Caramori
Endocrinologist
Dr Maria Luiza Caramori is an Endocrinologist at Cleveland Clinic, Ohio, US.
She received her medical degree from Federal University of Rio Grande do Sul School of Medicine and has been in practice for more than 20 years.
Ian de Boer
Professor of Medicine
Prof Ian de Boer is a Professor of Medicine at University of Washington, Washington, US.
He completed his Master of Science in epidemiology at University of Washington in 2005.
Prof de Boer's research interests include prevention and early identification of chronic kidney disease, diabetic kidney disease and vitamin D deficiency and kidney disease.
Erin D Michos
Associate Professor of Medicine and Director of Women's Cardiovascular Health
Dr Erin Michos is an Associate Professor of Medicine in the Division of Cardiology at the Johns Hopkins University School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women’s Cardiovascular Heath and Associate Director of Preventive Cardiology with the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Dr Michos is an internationally known expert in Preventive Cardiology and Women’s Health and has authored over 350 publications. Her research has focused on cardiovascular disease among women; coronary artery calcium, inflammatory markers, and other novel biomarkers of cardiovascular risk; lipids; and vitamin D and other supplements. She is an Associate Editor for Circulation and the American Journal of Preventive Cardiology.
Following receipt of her medical degree from Northwestern University, Dr. Michos…
Comments